{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:35:20Z","timestamp":1791999320102,"version":"4.4.0"},"reference-count":211,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,3,31]],"date-time":"2015-03-31T00:00:00Z","timestamp":1427760000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1038\/nrneph.2015.33","type":"journal-article","created":{"date-parts":[[2015,3,31]],"date-time":"2015-03-31T02:16:10Z","timestamp":1427768170000},"page":"329-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":335,"title":["Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis"],"prefix":"10.1038","volume":"11","author":[{"given":"Chandra","family":"Mohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaim","family":"Putterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,31]]},"reference":[{"key":"BFnrneph201533_CR1","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/art.37795","volume":"65","author":"CH Feldman","year":"2013","unstructured":"Feldman, C. H. et al. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000\u20132004. Arthritis Rheum. 65, 753\u2013763 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201533_CR2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMra071297","volume":"358","author":"A Rahman","year":"2008","unstructured":"Rahman, A. & Isenberg, D. A. Systemic lupus erythematosus. N. Engl. J. Med. 358, 929\u2013939 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201533_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/BOR.0000000000000089","volume":"26","author":"N Schwartz","year":"2014","unstructured":"Schwartz, N., Goilav, B. & Putterman, C. The pathogenesis, diagnosis and treatment of lupus nephritis. Curr. Opin. Rheumatol. 26, 502\u2013509 (2014).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrneph201533_CR4","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos, G. C. Systemic lupus erythematosus. N. Engl. J. Med. 365, 2110\u20132121 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201533_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.molimm.2013.11.013","volume":"62","author":"A Sang","year":"2014","unstructured":"Sang, A., Zheng, Y. Y. & Morel, L. Contributions of B cells to lupus pathogenesis. Mol. Immunol. 62, 329\u2013338 (2014).","journal-title":"Mol. Immunol."},{"key":"BFnrneph201533_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrrheum.2009.240","volume":"6","author":"A Davidson","year":"2010","unstructured":"Davidson, A. & Aranow, C. Lupus nephritis: lessons from murine models. Nat. Rev. Rheumatol. 6, 13\u201320 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"Suppl. 1","key":"BFnrneph201533_CR7","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/ar3910","volume":"15","author":"V Reddy","year":"2013","unstructured":"Reddy, V., Jayne, D., Close, D. & Isenberg, D. B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design. Arthritis Res. Ther. 15 (Suppl. 1), S2 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrneph201533_CR8","doi-asserted-by":"crossref","unstructured":"Liu, Y. & Anders, H. J. Lupus nephritis: from pathogenesis to targets for biologic treatment. Nephron Clin. Pract. (2014).","DOI":"10.1159\/000368581"},{"key":"BFnrneph201533_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/ki.2012.242","volume":"82","author":"A Okamoto","year":"2012","unstructured":"Okamoto, A. et al. Kidney-infiltrating CD4+ T-cell clones promote nephritis in lupus-prone mice. Kidney Int. 82, 969\u2013979 (2012).","journal-title":"Kidney Int."},{"key":"BFnrneph201533_CR10","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.4049\/jimmunol.0900385","volume":"183","author":"Z Zhang","year":"2009","unstructured":"Zhang, Z., Kyttaris, V. C. & Tsokos, G. C. The role of IL-23\/IL-17 axis in lupus nephritis. J. Immunol. 183, 3160\u20133169 (2009).","journal-title":"J. Immunol."},{"key":"BFnrneph201533_CR11","doi-asserted-by":"publisher","first-page":"980286","DOI":"10.1155\/2011\/980286","volume":"2011","author":"K Miyake","year":"2011","unstructured":"Miyake, K., Akahoshi, M. & Nakashima, H. Th subset balance in lupus nephritis. J. Biomed. Biotechnol. 2011, 980286 (2011).","journal-title":"J. Biomed. Biotechnol."},{"key":"BFnrneph201533_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.clim.2012.11.012","volume":"147","author":"M Aringer","year":"2013","unstructured":"Aringer, M., Gunther, C. & Lee-Kirsch, M. A. Innate immune processes in lupus erythematosus. Clin. Immunol. 147, 216\u2013222 (2013).","journal-title":"Clin. Immunol."},{"key":"BFnrneph201533_CR13","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1681\/ASN.2013010026","volume":"24","author":"M Lech","year":"2013","unstructured":"Lech, M. & Anders, H. J. The pathogenesis of lupus nephritis. J. Am. Soc. Nephrol. 24, 1357\u20131366 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201533_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/icb.2012.10","volume":"90","author":"K Kiefer","year":"2012","unstructured":"Kiefer, K., Oropallo, M. A., Cancro, M. P. & Marshak-Rothstein, A. Role of type I interferons in the activation of autoreactive B cells. Immunol. Cell Biol. 90, 498\u2013504 (2012).","journal-title":"Immunol. Cell Biol."},{"key":"BFnrneph201533_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/BOR.0b013e32832efff1","volume":"21","author":"H Bagavant","year":"2009","unstructured":"Bagavant, H. & Fu, S. M. Pathogenesis of kidney disease in systemic lupus erythematosus. Curr. Opin. Rheumatol. 21, 489\u2013494 (2009).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrneph201533_CR16","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/ar3528","volume":"13","author":"TK Nowling","year":"2011","unstructured":"Nowling, T. K. & Gilkeson, G. S. Mechanisms of tissue injury in lupus nephritis. Arthritis Res. Ther. 13, 250 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrneph201533_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/ar3844","volume":"14","author":"SG Guerra","year":"2012","unstructured":"Guerra, S. G., Vyse, T. J. & Cunninghame Graham, D. S. The genetics of lupus: a functional perspective. Arthritis Res. Ther. 14, 211 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrneph201533_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1586\/eci.10.8","volume":"6","author":"DL Flesher","year":"2010","unstructured":"Flesher, D. L., Sun, X., Behrens, T. W., Graham, R. R. & Criswell, L. A. Recent advances in the genetics of systemic lupus erythematosus. Expert Rev. Clin. Immunol. 6, 461\u2013479 (2010).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"BFnrneph201533_CR19","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nrrheum.2013.78","volume":"9","author":"JC Crispin","year":"2013","unstructured":"Crispin, J. C., Hedrich, C. M. & Tsokos, G. C. Gene-function studies in systemic lupus erythematosus. Nat. Rev. Rheumatol. 9, 476\u2013484 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrneph201533_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrrheum.2010.176","volume":"6","author":"Y Deng","year":"2010","unstructured":"Deng, Y. & Tsao, B. P. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat. Rev. Rheumatol. 6, 683\u2013692 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrneph201533_CR21","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/ng.200","volume":"40","author":"RR Graham","year":"2008","unstructured":"Graham, R. R. et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat. Genet. 40, 1059\u20131061 (2008).","journal-title":"Nat. Genet."},{"key":"BFnrneph201533_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2174\/1573397111309020003","volume":"9","author":"Y Guo","year":"2013","unstructured":"Guo, Y., Orme, J. & Mohan, C. A genopedia of lupus genes - lessons from gene knockouts. Curr. Rheumatol. Rev. 9, 90\u201399 (2013).","journal-title":"Curr. Rheumatol. Rev."},{"key":"BFnrneph201533_CR23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/annrheumdis-2011-200463","volume":"71","author":"TB Niewold","year":"2012","unstructured":"Niewold, T. B. et al. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus. Ann. Rheum. Dis. 71, 463\u2013468 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201533_CR24","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1136\/annrheumdis-2012-202024","volume":"72","author":"MA Jensen","year":"2013","unstructured":"Jensen, M. A. et al. Functional genetic polymorphisms in ILT3 are associated with decreased surface expression on dendritic cells and increased serum cytokines in lupus patients. Ann. Rheum. Dis. 72, 596\u2013601 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201533_CR25","doi-asserted-by":"publisher","first-page":"796","DOI":"10.4049\/jimmunol.0901748","volume":"184","author":"C Richez","year":"2010","unstructured":"Richez, C. et al. IFN regulatory factor 5 is required for disease development in the FcgammaRIIB\u2212\/\u2212Yaa and FcgammaRIIB\u2212\/\u2212 mouse models of systemic lupus erythematosus. J. Immunol. 184, 796\u2013806 (2010).","journal-title":"J. Immunol."},{"key":"BFnrneph201533_CR26","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/j.1440-1797.2010.01327.x","volume":"15","author":"L Qin","year":"2010","unstructured":"Qin, L. et al. Association of IRF5 gene polymorphisms and lupus nephritis in a Chinese population. Nephrology (Carlton) 15, 710\u2013713 (2010).","journal-title":"Nephrology (Carlton)"},{"key":"BFnrneph201533_CR27","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1073\/pnas.97.12.6670","volume":"97","author":"L Morel","year":"2000","unstructured":"Morel, L. et al. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl Acad. Sci. USA 97, 6670\u20136675 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201533_CR28","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.4049\/jimmunol.162.11.6492","volume":"162","author":"C Mohan","year":"1999","unstructured":"Mohan, C. et al. Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. J. Immunol. 162, 6492\u20136502 (1999).","journal-title":"J. Immunol."},{"key":"BFnrneph201533_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.clim.2003.09.007","volume":"110","author":"S Xie","year":"2004","unstructured":"Xie, S. & Mohan, C. Divide and conquer\u2014the power of congenic strains. Clin. Immunol. 110, 109\u2013111 (2004).","journal-title":"Clin. Immunol."},{"key":"BFnrneph201533_CR30","first-page":"207","volume":"53","author":"T Henry","year":"2005","unstructured":"Henry, T. & Mohan, C. Systemic lupus erythematosus\u2014recent clues from congenic strains. Arch. Immunol. Ther. Exp. (Warsz.) 53, 207\u2013212 (2005).","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"BFnrneph201533_CR31","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1172\/JCI5827","volume":"103","author":"C Mohan","year":"1999","unstructured":"Mohan, C. et al. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J. Clin. Invest. 103, 1685\u20131695 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201533_CR32","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.4049\/jimmunol.158.12.6019","volume":"158","author":"L Morel","year":"1997","unstructured":"Morel, L. et al. Functional dissection of systemic lupus erythematosus using congenic mouse strains. J. Immunol. 158, 6019\u20136028 (1997).","journal-title":"J. Immunol."},{"key":"BFnrneph201533_CR33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1189\/jlb.0212095","volume":"92","author":"SE Vaughn","year":"2012","unstructured":"Vaughn, S. E. et al. Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways. J. Leukoc. Biol. 92, 577\u2013591 (2012).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph201533_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-800266-7.00004-2","volume":"123","author":"AM Avalos","year":"2014","unstructured":"Avalos, A. M., Meyer-Wentrup, F. & Ploegh, H. L. B-cell receptor signaling in lymphoid malignancies and autoimmunity. Adv. Immunol. 123, 1\u201349 (2014).","journal-title":"Adv. Immunol."},{"key":"BFnrneph201533_CR35","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1586\/1744666X.2014.893827","volume":"10","author":"WH Shao","year":"2014","unstructured":"Shao, W. H. & Cohen, P. L. The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets. Expert Rev. Clin. Immunol. 10, 573\u2013582 (2014).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"BFnrneph201533_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/annrheumdis-2011-200085","volume":"71","author":"C Castillejo-Lopez","year":"2012","unstructured":"Castillejo-Lopez, C. et al. Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK. Ann. Rheum. Dis. 71, 136\u2013142 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201533_CR37","doi-asserted-by":"publisher","first-page":"7179","DOI":"10.4049\/jimmunol.175.11.7179","volume":"175","author":"JJ Coughlin","year":"2005","unstructured":"Coughlin, J. J. et al. RasGRP1 and RasGRP3 regulate B cell proliferation by facilitating B cell receptor-Ras signaling. J. Immunol. 175, 7179\u20137184 (2005).","journal-title":"J. Immunol."},{"key":"BFnrneph201533_CR38","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.redox.2014.05.005","volume":"2","author":"B Shao","year":"2014","unstructured":"Shao, B. et al. Hyperglycaemia promotes human brain microvascular endothelial cell apoptosis via induction of protein kinase C-\u03b2I and prooxidant enzyme NADPH oxidase. Redox Biol. 2, 694\u2013701 (2014).","journal-title":"Redox Biol."},{"key":"BFnrneph201533_CR39","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1091\/mbc.e14-01-0037","volume":"25,","author":"L Liu","year":"2014","unstructured":"Liu, L. et al. PKC\u03b2II acts downstream of chemoattractant receptors and mTORC2 to regulate cAMP production and myosin II activity in neutrophils. Mol. Biol. Cell 25, 1446\u2013145 (2014).","journal-title":"Mol. Biol. Cell"},{"key":"BFnrneph201533_CR40","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1182\/blood-2004-10-3916","volume":"105","author":"Y Zheng","year":"2005","unstructured":"Zheng, Y. et al. Phosphorylation of RasGRP3 on threonine 133 provides a mechanistic link between PKC and Ras signaling systems in B cells. Blood 105, 3648\u20133654. (2005).","journal-title":"Blood"},{"key":"BFnrneph201533_CR41","doi-asserted-by":"publisher","first-page":"10515","DOI":"10.1128\/MCB.24.24.10515-10528.2004","volume":"24","author":"DM Roberts","year":"2004","unstructured":"Roberts, D. M. et al. A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters. Mol. Cell Biol. 24, 10515\u201310528 (2004).","journal-title":"Mol. Cell Biol."},{"key":"BFnrneph201533_CR42","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/art.37825","volume":"65","author":"D Oleksyn","year":"2013","unstructured":"Oleksyn, D. et al. Protein kinase C\u03b2 is required for lupus development in Sle mice. Arthritis Rheum. 65, 1022\u20131031 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201533_CR43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000066856","volume":"6","author":"CC Yu","year":"2003","unstructured":"Yu, C. C., Mamchak, A. A. & DeFranco, A. L. Signaling mutations and autoimmunity. Curr. Dir. Autoimmun. 6, 61\u201388 (2003).","journal-title":"Curr. Dir. Autoimmun."},{"key":"BFnrneph201533_CR44","doi-asserted-by":"publisher","first-page":"919","DOI":"10.4049\/jimmunol.1301979","volume":"192","author":"C Lamagna","year":"2014","unstructured":"Lamagna, C. et al. B cell-specific loss of Lyn kinase leads to autoimmunity. J. Immunol. 192, 919\u2013928 (2014).","journal-title":"J. Immunol."},{"key":"BFnrneph201533_CR45","doi-asserted-by":"publisher","first-page":"875","DOI":"10.4049\/jimmunol.1300683","volume":"192","author":"Z Hua","year":"2014","unstructured":"Hua, Z. et al. Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice. J. Immunol. 192, 875\u2013885 (2014).","journal-title":"J. Immunol."},{"key":"BFnrneph201533_CR46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0960-9822(00)00024-5","volume":"11","author":"CC Yu","year":"2001","unstructured":"Yu, C. C., Yen, T. S., Lowell, C. A. & DeFranco, A. L. Lupus-like kidney disease in mice deficient in the Src family tyrosine kinases Lyn and Fyn. Curr. Biol. 11, 34\u201338 (2001).","journal-title":"Curr. Biol."},{"key":"BFnrneph201533_CR47","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/icb.2011.76","volume":"90","author":"EM Samuelson","year":"2012","unstructured":"Samuelson, E. M. et al. Blk haploinsufficiency impairs the development, but enhances the functional responses, of MZ B cells. Immunol. Cell Biol. 90, 620\u2013629 (2012).","journal-title":"Immunol. Cell Biol."},{"key":"BFnrneph201533_CR48","doi-asserted-by":"publisher","first-page":"e92054","DOI":"10.1371\/journal.pone.0092054","volume":"9","author":"EM Samuelson","year":"2014","unstructured":"Samuelson, E. M. et al. Reduced B lymphoid kinase (Blk) expression enhances proinflammatory cytokine production and induces nephrosis in C57BL\/6-lpr\/lpr mice. PLoS ONE 9, e92054 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrneph201533_CR49","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.1128\/MCB.14.11.7306","volume":"14","author":"A Hata","year":"1994","unstructured":"Hata, A. et al. Functional analysis of Csk in signal transduction through the B-cell antigen receptor. Mol. Cell Biol. 14, 7306\u20137313 (1994).","journal-title":"Mol. Cell Biol."},{"key":"BFnrneph201533_CR50","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/ng.2439","volume":"44","author":"N Manjarrez-Orduno","year":"2012","unstructured":"Manjarrez-Orduno, N. et al. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat. Genet. 44, 1227\u20131230 (2012).","journal-title":"Nat. Genet."},{"key":"BFnrneph201533_CR51","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1172\/JCI66963","volume":"123","author":"X Dai","year":"2013","unstructured":"Dai, X. et al. A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models. J. Clin. Invest. 123, 2024\u20132036 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201533_CR52","doi-asserted-by":"publisher","unstructured":"Bayley, R. et al. The autoimmune-associated genetic variant PTPN22 R620W enhances neutrophil activation and function in patients with rheumatoid arthritis and healthy individuals. Ann. Rheum. Dis. http:\/\/dx.doi.org\/10.1136\/annrheumdis-2013-204796 .","DOI":"10.1136\/annrheumdis-2013-204796"},{"key":"BFnrneph201533_CR53","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/ng.904","volume":"43","author":"J Zhang","year":"2011","unstructured":"Zhang, J. et al. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp\/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat. Genet. 43, 902\u2013907 (2011).","journal-title":"Nat. Genet."},{"key":"BFnrneph201533_CR54","doi-asserted-by":"publisher","first-page":"ra87","DOI":"10.1126\/scisignal.2003365","volume":"5","author":"RJ Brownlie","year":"2012","unstructured":"Brownlie, R. J. et al. Lack of the phosphatase PTPN22 increases adhesion of murine regulatory T cells to improve their immunosuppressive function. Sci. Signal. 5, ra87 (2012).","journal-title":"Sci. Signal."},{"key":"BFnrneph201533_CR55","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.immuni.2013.07.007","volume":"25","author":"LB Ivashkiv","year":"2013","unstructured":"Ivashkiv, L. B. PTPN22 in autoimmunity: different cell and different way. Immunity 25, 91\u201393 (2013).","journal-title":"Immunity"},{"key":"BFnrneph201533_CR56","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/416603a","volume":"416","author":"EA Leadbetter","year":"2002","unstructured":"Leadbetter, E. A. et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603\u2013607 (2002).","journal-title":"Nature"},{"key":"BFnrneph201533_CR57","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.177.5.1367","volume":"177","author":"C Mohan","year":"1993","unstructured":"Mohan, C., Adams, S., Stanik, V. & Datta, S. K. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177, 1367\u20131381 (1993).","journal-title":"J. Exp. Med."},{"key":"BFnrneph201533_CR58","doi-asserted-by":"publisher","first-page":"e1000696","DOI":"10.1371\/journal.pgen.1000696","volume":"5","author":"LF Barcellos","year":"2009","unstructured":"Barcellos, L. F. et al. High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet. 5, e1000696 (2009).","journal-title":"PLoS Genet."},{"key":"BFnrneph201533_CR59","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/sj.ejhg.5201827","volume":"15","author":"RR Graham","year":"2007","unstructured":"Graham, R. R. et al. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur. J. Hum. Genet. 15, 823\u2013830 (2007).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnrneph201533_CR60","doi-asserted-by":"publisher","first-page":"e1000024","DOI":"10.1371\/journal.pgen.1000024","volume":"4","author":"MM Fernando","year":"2008","unstructured":"Fernando, M. M. et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet. 4, e1000024 (2008).","journal-title":"PLoS Genet."},{"key":"BFnrneph201533_CR61","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-065X.2009.00784.x","volume":"229","author":"AH Sharpe","year":"2009","unstructured":"Sharpe, A. H. Mechanisms of costimulation. Immunol. Rev. 229, 5\u201311 (2009).","journal-title":"Immunol. Rev."},{"key":"BFnrneph201533_CR62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/0256-4947.75775","volume":"31","author":"MN Farres","year":"2011","unstructured":"Farres, M. N., Al-Zifzaf, D. S., Aly, A. A. & Abd Raboh, N. M. OX40\/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis. Ann. Saudi Med. 31, 29\u201334 (2011).","journal-title":"Ann. Saudi Med."},{"key":"BFnrneph201533_CR63","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ajhg.2012.11.018","volume":"92","author":"W Yang","year":"2013","unstructured":"Yang, W. et al. Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians. Am. J. Hum. Genet. 92, 41\u201351 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph201533_CR64","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/ar2964","volume":"12","author":"K Shah","year":"2010","unstructured":"Shah, K. et al. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res. Ther. 12, R53 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrneph201533_CR65","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.4049\/jimmunol.1001983","volume":"186","author":"A Chang","year":"2011","unstructured":"Chang, A. et al. In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J. Immunol. 186, 1849\u20131860 (2011).","journal-title":"J. Immunol."},{"key":"BFnrneph201533_CR66","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nm1763","volume":"14","author":"K Neubert","year":"2008","unstructured":"Neubert, K. et al. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat. Med. 14, 748\u2013755 (2008).","journal-title":"Nat. Med."},{"key":"BFnrneph201533_CR67","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/art.10949","volume":"48","author":"AM Jacobi","year":"2003","unstructured":"Jacobi, A. M. et al. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 48, 1332\u20131342 (2003).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201533_CR68","doi-asserted-by":"publisher","first-page":"e1000841","DOI":"10.1371\/journal.pgen.1000841","volume":"6","author":"W Yang","year":"2010","unstructured":"Yang, W. et al. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet. 6, e1000841 (2010).","journal-title":"PLoS Genet."},{"key":"BFnrneph201533_CR69","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/intimm\/dxh295","volume":"17","author":"D Wang","year":"2005","unstructured":"Wang, D. et al. Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease. Int. Immunol. 17, 1179\u20131191 (2005).","journal-title":"Int. Immunol."},{"key":"BFnrneph201533_CR70","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1084\/jem.20110658","volume":"208","author":"SJ Kim","year":"2011","unstructured":"Kim, S. J. et al. Tolerogenic function of Blimp-1 in dendritic cells. J. Exp. Med. 208, 2193\u20132199 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnrneph201533_CR71","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.humimm.2012.11.019","volume":"74","author":"Z Zhou","year":"2013","unstructured":"Zhou, Z. et al. Blimp-1 siRNA inhibits B cell differentiation and prevents the development of lupus in mice. Hum. Immunol. 74, 297\u2013301 (2013).","journal-title":"Hum. Immunol."},{"key":"BFnrneph201533_CR72","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4049\/jimmunol.1400931","volume":"193","author":"G Amarilyo","year":"2014","unstructured":"Amarilyo, G., Lourenco, E. V., Shi, F. D. & La Cava, A. IL-17 promotes murine lupus. J. Immunol. 193, 540\u2013543 (2014).","journal-title":"J. Immunol."},{"key":"BFnrneph201533_CR73","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/art.38955","volume":"67","author":"T Schmidt","year":"2015","unstructured":"Schmidt, T. et al. Function of the Th17\/interleukin-17A immune response in murine lupus nephritis. Arthritis Rheumatol. 67, 475\u2013487 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrneph201533_CR74","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1002\/art.30452","volume":"63","author":"W Tan","year":"2011","unstructured":"Tan, W. et al. Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups. Arthritis Rheum. 63, 2755\u20132763 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201533_CR75","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/0961203314552117","volume":"24","author":"YA Lashine","year":"2014","unstructured":"Lashine, Y. A., Salah, S., Aboelenein, H. R. & Abdelaziz, A. I. Correcting the expression of miRNA-155 represses PP2Ac and enhances the release of IL-2 in PBMCs of juvenile SLE patients. Lupus 24, 240\u2013247 (2014).","journal-title":"Lupus"},{"key":"BFnrneph201533_CR76","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.4049\/jimmunol.1200143","volume":"188","author":"JC Crispin","year":"2012","unstructured":"Crispin, J. C. et al. Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism. J. Immunol. 188, 3567\u20133571 (2012).","journal-title":"J. Immunol."},{"key":"BFnrneph201533_CR77","doi-asserted-by":"publisher","first-page":"26775","DOI":"10.1074\/jbc.M113.483743","volume":"288","author":"SA Apostolidis","year":"2013","unstructured":"Apostolidis, S. A. et al. Protein phosphatase 2A enables expression of interleukin 17 (IL-17) through chromatin remodeling. J. Biol. Chem. 288, 26775\u201326784 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201533_CR78","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1002\/art.34567","volume":"64","author":"IB Richman","year":"2012","unstructured":"Richman, I. B. et al. European genetic ancestry is associated with a decreased risk of lupus nephritis. Arthritis Rheum. 64, 3374\u20133382 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201533_CR79","doi-asserted-by":"publisher","first-page":"e1001311","DOI":"10.1371\/journal.pgen.1001311","volume":"7","author":"KE Taylor","year":"2011","unstructured":"Taylor, K. E. et al. Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. PLoS Genet. 7, e1001311 (2011).","journal-title":"PLoS Genet."},{"key":"BFnrneph201533_CR80","doi-asserted-by":"publisher","first-page":"e1000084","DOI":"10.1371\/journal.pgen.1000084","volume":"4","author":"KE Taylor","year":"2008","unstructured":"Taylor, K. E. et al. Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genet. 4, e1000084 (2008).","journal-title":"PLoS Genet."},{"key":"BFnrneph201533_CR81","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.4049\/jimmunol.171.3.1564","volume":"171","author":"CO Jacob","year":"2003","unstructured":"Jacob, C. O. et al. Pivotal role of Stat4 and Stat6 in the pathogenesis of the lupus-like disease in the New Zealand mixed 2328 mice. J. Immunol. 171, 1564\u20131571 (2003).","journal-title":"J. Immunol."},{"key":"BFnrneph201533_CR82","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s00011-012-0535-6","volume":"61","author":"P Rajabi","year":"2012","unstructured":"Rajabi, P., Alaee, M., Mousavizadeh, K. & Samadikuchaksaraei, A. Altered expression of TNFSF4 and TRAF2 mRNAs in peripheral blood mononuclear cells in patients with systemic lupus erythematosus: association with atherosclerotic symptoms and lupus nephritis. Inflamm. Res. 61, 1347\u20131354 (2012).","journal-title":"Inflamm. Res."},{"key":"BFnrneph201533_CR83","first-page":"597921","volume":"2013","author":"XJ Zhou","year":"2013","unstructured":"Zhou, X. J. et al. A replication study from Chinese supports association between lupus-risk allele in TNFSF4 and renal disorder. Biomed. Res. Int. 2013, 597921 (2013).","journal-title":"Biomed. Res. Int."},{"key":"BFnrneph201533_CR84","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1136\/ard.2011.154104","volume":"70","author":"E Sanchez","year":"2011","unstructured":"Sanchez, E. et al. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann. Rheum. Dis. 70, 1752\u20131757 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201533_CR85","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1177\/0961203310371161","volume":"19","author":"G Obermoser","year":"2010","unstructured":"Obermoser, G. & Pascual, V. The interferon-alpha signature of systemic lupus erythematosus. Lupus 19, 1012\u20131019 (2010).","journal-title":"Lupus"},{"key":"BFnrneph201533_CR86","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.4049\/jimmunol.0900742","volume":"183","author":"AM Fairhurst","year":"2009","unstructured":"Fairhurst, A. M. et al. Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis. J. Immunol. 183, 6831\u20136838 (2009).","journal-title":"J. Immunol."},{"key":"BFnrneph201533_CR87","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1073\/pnas.0914902107","volume":"107","author":"A Triantafyllopoulou","year":"2010","unstructured":"Triantafyllopoulou, A. et al. Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc. Natl Acad. Sci. USA 107, 3012\u20133017 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201533_CR88","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0961203310367918","volume":"19","author":"CF He","year":"2010","unstructured":"He, C. F. et al. TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population. Lupus 19, 1181\u20131186 (2010).","journal-title":"Lupus"},{"key":"BFnrneph201533_CR89","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.4049\/jimmunol.164.9.4659","volume":"164","author":"DM Frucht","year":"2000","unstructured":"Frucht, D. M. et al. STAT4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J. Immunol. 164, 4659\u20134664 (2000).","journal-title":"J. Immunol."},{"key":"BFnrneph201533_CR90","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1385\/IR:31:3:231","volume":"31","author":"MH Kaplan","year":"2005","unstructured":"Kaplan, M. H. STAT4: a critical regulator of inflammation in vivo. Immunol. Res. 31, 231\u2013242 (2005).","journal-title":"Immunol. Res."},{"key":"BFnrneph201533_CR91","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1172\/JCI28508","volume":"116","author":"Y Iwakura","year":"2006","unstructured":"Iwakura, Y. & Ishigame, H. The IL-23\/IL-17 axis in inflammation. J. Clin. Invest. 116, 1218\u20131222 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201533_CR92","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","volume":"14","author":"LB Ivashkiv","year":"2014","unstructured":"Ivashkiv, L. B. & Donlin, L. T. Regulation of type I interferon responses. Nat. Rev. Immunol. 14, 36\u201349 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneph201533_CR93","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1089\/jir.2011.0045","volume":"31","author":"KB Elkon","year":"2011","unstructured":"Elkon, K. B. & Stone, V. V. Type I interferon and systemic lupus erythematosus. J. Interferon Cytokine Res. 31, 803\u2013812 (2011).","journal-title":"J. Interferon Cytokine Res."},{"key":"BFnrneph201533_CR94","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/tan.12349","volume":"83","author":"J Dang","year":"2014","unstructured":"Dang, J. et al. Gene-gene interactions of IRF5, STAT4, IKZF1 and ETS1 in systemic lupus erythematosus. Tissue Antigens 83, 401\u2013408 (2014).","journal-title":"Tissue Antigens"},{"key":"BFnrneph201533_CR95","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1046\/j.1523-1755.2003.00873.x","volume":"63","author":"FB Karassa","year":"2003","unstructured":"Karassa, F. B. et al. The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis. Kidney Int. 63, 1475\u20131482 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph201533_CR96","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/08916930701763710","volume":"40","author":"EE Brown","year":"2007","unstructured":"Brown, E. E., Edberg, J. C. & Kimberly, R. P. Fc receptor genes and the systemic lupus erythematosus diathesis. Autoimmunity 40, 567\u2013581 (2007).","journal-title":"Autoimmunity"},{"key":"BFnrneph201533_CR97","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nm1288","volume":"11","author":"RA Floto","year":"2005","unstructured":"Floto, R. A. et al. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat. Med. 11, 1056\u20131058 (2005).","journal-title":"Nat. Med."},{"key":"BFnrneph201533_CR98","doi-asserted-by":"publisher","first-page":"E640","DOI":"10.1002\/humu.20997","volume":"30","author":"WB Breunis","year":"2009","unstructured":"Breunis, W. B. et al. Copy number variation at the FCGR locus includes FCGR3A, FCGRXXXXX2C and FCGR3B but not FCGR2A and FCGR2B. Hum. Mutat. 30, E640\u2013E650 (2009).","journal-title":"Hum. Mutat."},{"key":"BFnrneph201533_CR99","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/ng2046","volume":"39","author":"M Fanciulli","year":"2007","unstructured":"Fanciulli, M. et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat. Genet. 39, 721\u2013723 (2007).","journal-title":"Nat. Genet."},{"key":"BFnrneph201533_CR100","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/ejhg.2010.56","volume":"18","author":"DL Morris","year":"2010","unstructured":"Morris, D. L. et al. Evidence for both copy number and allelic (NA1\/NA2) risk at the FCGR3B locus in systemic lupus erythematosus. Eur. J. Hum. Genet. 18, 1027\u20131031 (2010).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnrneph201533_CR101","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1126\/science.279.5353.1052","volume":"279","author":"R Clynes","year":"1998","unstructured":"Clynes, R., Dumitru, C. & Ravetch, J. V. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279, 1052\u20131054 (1998).","journal-title":"Science"},{"key":"BFnrneph201533_CR102","doi-asserted-by":"publisher","first-page":"7287","DOI":"10.4049\/jimmunol.177.10.7287","volume":"177","author":"A Bergtold","year":"2006","unstructured":"Bergtold, A. et al. FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis. J. Immunol. 177, 7287\u20137295 (2006).","journal-title":"J. Immunol."},{"key":"BFnrneph201533_CR103","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/jlb.63.5.521","volume":"63","author":"G S\u00e1nchez-Mejorada","year":"1998","unstructured":"S\u00e1nchez-Mejorada, G. & Rosales, C. Signal transduction by immunoglobulin Fc receptors. J. Leukoc. Biol. 63, 521\u2013533 (1998).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph201533_CR104","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12026-012-8270-1","volume":"53","author":"T Celhar","year":"2012","unstructured":"Celhar, T., Magalh\u00e3es, R. & Fairhurst, A. M. TLR7 and TLR9 in SLE: when sensing self goes wrong. Immunol. Res. 53, 58\u201377 (2012).","journal-title":"Immunol. Res."},{"key":"BFnrneph201533_CR105","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3389\/fimmu.2013.00319","volume":"4","author":"M Shrivastav","year":"2013","unstructured":"Shrivastav, M. & Niewold, T. B. Nucleic acid sensors and type I interferon production in systemic lupus erythematosus. Front. Immunol. 4, 319 (2013).","journal-title":"Front. Immunol."},{"key":"BFnrneph201533_CR106","first-page":"397","volume":"28","author":"XJ Zhou","year":"2010","unstructured":"Zhou, X. J. et al. Association of TLR9 gene polymorphisms with lupus nephritis in a Chinese Han population. Clin. Exp. Rheumatol. 28, 397\u2013400 (2010).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrneph201533_CR107","doi-asserted-by":"publisher","first-page":"6256","DOI":"10.1073\/pnas.0901181106","volume":"106","author":"CO Jacob","year":"2009","unstructured":"Jacob, C. O. et al. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc. Natl Acad. Sci. USA 106, 6256\u20136261 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201533_CR108","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1002\/eji.200737815","volume":"37","author":"FJ Barrat","year":"2007","unstructured":"Barrat, F. J. et al. Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms. Eur. J. Immunol. 37, 3582\u20133586 (2007).","journal-title":"Eur. J. Immunol."},{"key":"BFnrneph201533_CR109","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","volume":"25","author":"SR Christensen","year":"2006","unstructured":"Christensen, S. R. et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25, 417\u2013428 (2006).","journal-title":"Immunity"},{"key":"BFnrneph201533_CR110","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bcp.2009.02.009","volume":"78","author":"L Verstrepen","year":"2009","unstructured":"Verstrepen, L. et al. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling. Biochem. Pharmacol. 78, 105\u2013114 (2009).","journal-title":"Biochem. Pharmacol."},{"key":"BFnrneph201533_CR111","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ajhg.2014.12.024","volume":"96","author":"MJ Lewis","year":"2015","unstructured":"Lewis, M. J. et al. BE2L3 polymorphism amplifies NF-\u03baB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am. J. Hum. Genet. 96, 221\u2013234 (2015).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph201533_CR112","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00296-013-2864-3","volume":"34","author":"XB Zuo","year":"2014","unstructured":"Zuo, X. B. et al. Variants in TNFSF4, TNFAIP3, TNIP1, BLK, SLC15A4 and UBE2L3 interact to confer risk of systemic lupus erythematosus in Chinese population. Rheumatol. Int. 34, 459\u2013464 (2014).","journal-title":"Rheumatol. Int."},{"key":"BFnrneph201533_CR113","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/eji.201041313","volume":"41","author":"N Hovelmeyer","year":"2011","unstructured":"Hovelmeyer, N. et al. A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies. Eur. J. Immunol. 41, 595\u2013601 (2011).","journal-title":"Eur. J. Immunol."},{"key":"BFnrneph201533_CR114","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1681\/ASN.2013020148","volume":"24","author":"DJ Caster","year":"2013","unstructured":"Caster, D. J. et al. ABIN1 dysfunction as a genetic basis for lupus nephritis. J. Am. Soc. Nephrol. 24, 1743\u20131754 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201533_CR115","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/gene.2009.31","volume":"10","author":"JS Bates","year":"2009","unstructured":"Bates, J. S. et al. Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. Genes Immun. 10, 470\u2013477 (2009).","journal-title":"Genes Immun."},{"key":"BFnrneph201533_CR116","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1002\/art.38117","volume":"65","author":"Y Zhou","year":"2013","unstructured":"Zhou, Y. et al. Multiple lupus-associated ITGAM variants alter Mac-1 functions on neutrophils. Arthritis Rheum. 65, 2907\u20132916 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201533_CR117","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1177\/0961203313491851","volume":"22","author":"SC Fagerholm","year":"2013","unstructured":"Fagerholm, S. C. et al. The CD11b-integrin (ITGAM) and systemic lupus erythematosus. Lupus 22, 657\u2013663 (2013).","journal-title":"Lupus"},{"key":"BFnrneph201533_CR118","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1365-2249.1993.tb03377.x","volume":"92","author":"GD Ross","year":"1993","unstructured":"Ross, G. D. & Ve\u02d8tvicka, V. CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin. Exp. Immunol. 92, 181\u2013184 (1993).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrneph201533_CR119","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1136\/ard.2009.120543","volume":"69","author":"X Kim-Howard","year":"2010","unstructured":"Kim-Howard, X. et al. ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry. Ann. Rheum. Dis. 69, 1329\u20131332 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201533_CR120","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1093\/hmg\/ddp118","volume":"18","author":"W Yang","year":"2009","unstructured":"Yang, W. et al. ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum. Mol. Genet. 18, 2063\u20132070 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph201533_CR121","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.autrev.2011.10.010","volume":"11","author":"J Orme","year":"2012","unstructured":"Orme, J. & Mohan, C. Macrophages and neutrophils in SLE-An online molecular catalog. Autoimmun. Rev. 11, 365\u2013372 (2012).","journal-title":"Autoimmun. Rev."},{"key":"BFnrneph201533_CR122","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nrrheum.2013.78","volume":"9","author":"JC Crisp\u00edn","year":"2013","unstructured":"Crisp\u00edn, J. C., Hedrich, C. M. & Tsokos, G. C. Gene-function studies in systemic lupus erythematosus. Nat. Rev. Rheumatol. 9, 476\u2013484 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrneph201533_CR123","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2119\/molmed.2013.00010","volume":"19","author":"N Seredkina","year":"2013","unstructured":"Seredkina, N. et al. Lupus nephritis: enigmas, conflicting models and an emerging concept. Mol. Med. 19, 161\u2013169 (2013).","journal-title":"Mol. Med."},{"key":"BFnrneph201533_CR124","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00281-014-0428-6","volume":"36","author":"OP Rekvig","year":"2014","unstructured":"Rekvig, O. P. & Van der Vlag, J. The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved. Semin. Immunopathol. 36, 301\u2013311 (2014).","journal-title":"Semin. Immunopathol."},{"key":"BFnrneph201533_CR125","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3899\/jrheum.110863","volume":"39","author":"TB Zhou","year":"2012","unstructured":"Zhou, T. B. et al. Relationship between angiotensin-converting enzyme insertion\/deletion gene polymorphism and systemic lupus erythematosus\/lupus nephritis: a systematic review and metaanalysis. J. Rheumatol. 39, 686\u2013693 (2012).","journal-title":"J. Rheumatol."},{"key":"BFnrneph201533_CR126","doi-asserted-by":"publisher","first-page":"e1001323","DOI":"10.1371\/journal.pgen.1001323","volume":"7","author":"SA Chung","year":"2011","unstructured":"Chung, S. A. et al. Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet. 7, e1001323 (2011).","journal-title":"PLoS Genet."},{"key":"BFnrneph201533_CR127","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1172\/JCI36728","volume":"119","author":"K Liu","year":"2009","unstructured":"Liu, K. et al. Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. J. Clin. Invest. 119, 911\u2013923 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201533_CR128","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1177\/0961203307088130","volume":"17","author":"H Ciferska","year":"2008","unstructured":"Ciferska, H. et al. Expression of nucleic acid binding Toll-like receptors in control, lupus and transplanted kidneys--a preliminary pilot study. Lupus 17, 580\u2013585 (2008).","journal-title":"Lupus"},{"key":"BFnrneph201533_CR129","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1177\/0961203309103054","volume":"18","author":"ED Papadimitraki","year":"2009","unstructured":"Papadimitraki, E. D. et al. Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: implications for the amplification of the inflammatory response. Lupus 18, 831\u2013835 (2009).","journal-title":"Lupus"},{"key":"BFnrneph201533_CR130","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1093\/ndt\/gfl336","volume":"21","author":"PS Patole","year":"2006","unstructured":"Patole, P. S. et al. Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice. Nephrol. Dial. Transplant. 21, 3062\u20133073 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201533_CR131","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1186\/ar2226","volume":"9","author":"SM Ka","year":"2007","unstructured":"Ka, S. M. et al. Mesangial cells of lupus-prone mice are sensitive to chemokine production. Arthritis Res. Ther. 9, R67 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrneph201533_CR132","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1748-1716.2010.02097.x","volume":"199","author":"S Liu","year":"2010","unstructured":"Liu, S. et al. TRAF6 knockdown promotes survival and inhibits inflammatory response to lipopolysaccharides in rat primary renal proximal tubule cells. Acta Physiol. (Oxf.) 199, 339\u2013346 (2010).","journal-title":"Acta Physiol. (Oxf.)"},{"key":"BFnrneph201533_CR133","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/art.22524","volume":"56","author":"A Benigni","year":"2007","unstructured":"Benigni, A. et al. Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus. Arthritis Rheum. 56, 1569\u20131578 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201533_CR134","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1093\/ndt\/gfq058","volume":"25","author":"H Machida","year":"2010","unstructured":"Machida, H. et al. Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis. Nephrol. Dial. Transplant. 25, 2530\u20132537 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201533_CR135","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.5301\/jn.5000091","volume":"25","author":"M Frieri","year":"2012","unstructured":"Frieri, M. et al. Toll-like receptor 9 and vascular endothelial growth factor levels in human kidneys from lupus nephritis patients. J. Nephrol. 25, 1041\u20131046 (2012).","journal-title":"J. Nephrol."},{"key":"BFnrneph201533_CR136","doi-asserted-by":"publisher","first-page":"F867","DOI":"10.1152\/ajprenal.90213.2008","volume":"296","author":"J Lichtnekert","year":"2009","unstructured":"Lichtnekert, J. et al. Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2\/Myd88 rather than Tlr3\/Trif. Am. J. Physiol. Renal Physiol. 296, F867\u2013F874 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201533_CR137","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1111\/j.1523-1755.2005.00564.x","volume":"68","author":"U Kunter","year":"2005","unstructured":"Kunter, U. et al. Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells. Kidney Int. 68, 1520\u20131532 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph201533_CR138","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00109-008-0405-4","volume":"86","author":"J Lutz","year":"2008","unstructured":"Lutz, J. et al. The A20 gene protects kidneys from ischaemia\/reperfusion injury by suppressing pro-inflammatory activation. J. Mol. Med. (Berl.) 86, 1329\u20131339 (2008).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"BFnrneph201533_CR139","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/jcp.22851","volume":"227","author":"CG da Silva","year":"2012","unstructured":"da Silva, C. G. et al. Hepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-\u03baB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation. J. Cell Physiol. 227, 1382\u20131390 (2012).","journal-title":"J. Cell Physiol."},{"key":"BFnrneph201533_CR140","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI20402","volume":"113","author":"J Reiser","year":"2004","unstructured":"Reiser, J. et al. Induction of B7\u20131 in podocytes is associated with nephrotic syndrome. J. Clin. Invest. 113, 1390\u20131397 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201533_CR141","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/ndt\/gfr271","volume":"27","author":"M Shimada","year":"2012","unstructured":"Shimada, M. et al. Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-\u03baB-dependent pathway. Nephrol. Dial. Transplant. 27, 81\u201389 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201533_CR142","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/ndt\/gfs543","volume":"28","author":"T Ishimoto","year":"2013","unstructured":"Ishimoto, T. et al. Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice. Nephrol. Dial. Transplant. 28, 1439\u20131446 (2013).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201533_CR143","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","volume":"369","author":"CC Yu","year":"2013","unstructured":"Yu, C. C. et al. Abatacept in B7-1-positive proteinuric kidney disease. N. Engl. J. Med. 369, 2416\u20132423 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201533_CR144","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.4049\/jimmunol.1102357","volume":"187","author":"K Ichinose","year":"2011","unstructured":"Ichinose, K. et al. Cutting edge: calcium\/calmodulin-dependent protein kinase type IV is essential for mesangial cell proliferation and lupus nephritis. J. Immunol. 187, 5500\u20135504 (2011).","journal-title":"J. Immunol."},{"key":"BFnrneph201533_CR145","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2011.05.004","volume":"37","author":"SM Fu","year":"2011","unstructured":"Fu, S. M., Deshmukh, U. S. & Gaskin, F. Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR. J. Autoimmun. 37, 104\u2013112 (2011).","journal-title":"J. Autoimmun."},{"key":"BFnrneph201533_CR146","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1084\/jem.20130731","volume":"210","author":"Y Ge","year":"2013","unstructured":"Ge, Y. et al. Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis. J. Exp. Med. 210, 2387\u20132401 (2013).","journal-title":"J. Exp. Med."},{"key":"BFnrneph201533_CR147","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coi.2014.10.004","volume":"31","author":"C Dai","year":"2014","unstructured":"Dai, C. et al. Genetics of systemic lupus erythematosus: immune responses and end organ resistance to damage. Curr. Opin. Immunol. 31, 87\u201396 (2014).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnrneph201533_CR148","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2174\/1573397111309020003","volume":"9","author":"Y Guo","year":"2013","unstructured":"Guo, Y., Orme, J. & Mohan, C. A genopedia of lupus genes - lessons from gene knockouts. Curr. Rheumatol. Rev. 9, 90\u201399 (2013).","journal-title":"Curr. Rheumatol. Rev."},{"key":"BFnrneph201533_CR149","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/ar3206","volume":"13","author":"WH Shao","year":"2011","unstructured":"Shao, W. H. & Cohen, P. L. Disturbances of apoptotic cell clearance in systemic lupus erythematosus. Arthritis Res. Ther. 13, 202 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrneph201533_CR150","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fimmu.2014.00164","volume":"5","author":"E Pieterse","year":"2014","unstructured":"Pieterse, E. & Van der Vlag, J. Breaking immunological tolerance in systemic lupus erythematosus. Front. Immunol. 5, 164 (2014).","journal-title":"Front. Immunol."},{"key":"BFnrneph201533_CR151","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1172\/JCI39492","volume":"120","author":"B Hartleben","year":"2010","unstructured":"Hartleben, B. et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J. Clin. Invest. 120, 1084\u20131096 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201533_CR152","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.autrev.2014.10.003","volume":"14","author":"G Yaniv","year":"2015","unstructured":"Yaniv, G. et al. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmun. Rev. 14, 75\u201379 (2015).","journal-title":"Autoimmun. Rev."},{"key":"BFnrneph201533_CR153","doi-asserted-by":"publisher","first-page":"368274","DOI":"10.1155\/2014\/368274","volume":"2014","author":"S Mehra","year":"2014","unstructured":"Mehra, S. & Fritzler, M. J. The spectrum of anti-chromatin\/nucleosome autoantibodies: independent and interdependent biomarkers of disease. J. Immunol. Res. 2014, 368274 (2014).","journal-title":"J. Immunol. Res."},{"key":"BFnrneph201533_CR154","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.autrev.2012.09.003","volume":"12","author":"M Gatto","year":"2013","unstructured":"Gatto, M. et al. Emerging and critical issues in the pathogenesis of lupus. Autoimmun. Rev. 12, 523\u2013536 (2013).","journal-title":"Autoimmun. Rev."},{"key":"BFnrneph201533_CR155","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00281-014-0428-6","volume":"36","author":"OP Rekvig","year":"2014","unstructured":"Rekvig, O. P. & Van der Vlag, J. The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved. Semin. Immunopathol. 36, 301\u2013311 (2014).","journal-title":"Semin. Immunopathol."},{"key":"BFnrneph201533_CR156","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nrrheum.2010.46","volume":"6","author":"LE Munoz","year":"2010","unstructured":"Munoz, L. E. et al. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat. Rev. Rheumatol. 6, 280\u2013289 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrneph201533_CR157","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1084\/jem.20012094","volume":"196","author":"PL Cohen","year":"2002","unstructured":"Cohen, P. L. et al. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196, 135\u2013140 (2002).","journal-title":"J. Exp. Med."},{"key":"BFnrneph201533_CR158","doi-asserted-by":"publisher","first-page":"8706","DOI":"10.1073\/pnas.0910359107","volume":"107","author":"R Rodriguez-Manzanet","year":"2010","unstructured":"Rodriguez-Manzanet, R. et al. T and B cell hyperactivity and autoimmunity associated with niche-specific defects in apoptotic body clearance in TIM-4-deficient mice. Proc. Natl Acad. Sci. USA 107, 8706\u20138711 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201533_CR159","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/BOR.0b013e3283546703","volume":"24","author":"JS Knight","year":"2012","unstructured":"Knight, J. S. & Kaplan, M. J. Lupus neutrophils: 'NET' gain in understanding lupus pathogenesis. Curr. Opin. Rheumatol. 24, 441\u2013450 (2012).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrneph201533_CR160","doi-asserted-by":"publisher","first-page":"138","DOI":"10.2119\/molmed.2013.00164","volume":"20","author":"M Magna","year":"2014","unstructured":"Magna, M. & Pisetsky, D. S. The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases. Mol. Med. 20, 138\u2013146 (2014).","journal-title":"Mol. Med."},{"key":"BFnrneph201533_CR161","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/rheumatology\/kel449","volume":"46","author":"DS Cunninghame Graham","year":"2007","unstructured":"Cunninghame Graham, D. S., Akil, M. & Vyse, T. J. Association of polymorphisms across the tyrosine kinase gene, TYK2 in UK SLE families. Rheumatology (Oxford) 46, 927\u2013930 (2007).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrneph201533_CR162","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s10495-010-0530-8","volume":"15","author":"D Mevorach","year":"2010","unstructured":"Mevorach, D. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system. Apoptosis 15, 1114\u20131123 (2010).","journal-title":"Apoptosis"},{"key":"BFnrneph201533_CR163","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1136\/annrheumdis-2014-205287","volume":"73","author":"J Leffler","year":"2014","unstructured":"Leffler, J., Bengtsson, A. A. & Blom, A. M. The complement system in systemic lupus erythematosus: an update. Ann. Rheum. Dis. 73, 1601\u20131606 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201533_CR164","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/ar3378","volume":"13","author":"R Saxena","year":"2011","unstructured":"Saxena, R., Mahajan, T. & Mohan, C. Lupus nephritis: current update. Arthritis Res. Ther. 13, 240 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrneph201533_CR165","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000368581","volume":"128","author":"Y Liu","year":"2014","unstructured":"Liu, Y. & Anders, H. J. Lupus nephritis: from pathogenesis to targets for biologic treatment. Nephron Clin. Pract. 128, 224\u2013231 (2014).","journal-title":"Nephron Clin. Pract."},{"key":"BFnrneph201533_CR166","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nm.2752","volume":"18","author":"Z Liu","year":"2012","unstructured":"Liu, Z. & Davidson, A. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat. Med. 18, 871\u2013882 (2012).","journal-title":"Nat. Med."},{"key":"BFnrneph201533_CR167","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1568-9972(03)00082-X","volume":"2","author":"C Putterman","year":"2004","unstructured":"Putterman, C. New approaches to the renal pathogenicity of anti-DNA antibodies in systemic lupus erythematosus. Autoimmun. Rev. 2, 7\u201311 (2004).","journal-title":"Autoimmun. Rev."},{"key":"BFnrneph201533_CR168","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/ng.79","volume":"40","author":"SV Kozyrev","year":"2008","unstructured":"Kozyrev, S. V. et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat. Genet. 40, 211\u2013216 (2008).","journal-title":"Nat. Genet."},{"key":"BFnrneph201533_CR169","doi-asserted-by":"publisher","first-page":"e1000841","DOI":"10.1371\/journal.pgen.1000841","volume":"6","author":"W Yang","year":"2010","unstructured":"Yang, W. et al. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet. 6, e1000841 (2010).","journal-title":"PLoS Genet."},{"key":"BFnrneph201533_CR170","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1002\/art.30563","volume":"63","author":"E Sanchez","year":"2011","unstructured":"Sanchez, E. et al. Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis Rheum. 63, 3493\u20133501 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201533_CR171","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1056\/NEJMoa0707865","volume":"358","author":"G Hom","year":"2008","unstructured":"Hom, G. et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N. Engl. J. Med. 358, 900\u2013909 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201533_CR172","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/ng.472","volume":"41","author":"JW Han","year":"2009","unstructured":"Han, J. W. et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 41, 1234\u20131237 (2009).","journal-title":"Nat. Genet."},{"key":"BFnrneph201533_CR173","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ajhg.2014.03.008","volume":"94","author":"JM Guthridge","year":"2014","unstructured":"Guthridge, J. M. et al. Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription. Am. J. Hum. Genet. 94, 586\u2013598 (2014).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph201533_CR174","doi-asserted-by":"publisher","first-page":"e1002455","DOI":"10.1371\/journal.pgen.1002455","volume":"8","author":"Y Okada","year":"2012","unstructured":"Okada, Y. et al. A genome-wide association study identified AFF1 as a susceptibility locus for systemic lupus eyrthematosus in Japanese. PLoS Genet. 8, e1002455 (2012).","journal-title":"PLoS Genet."},{"key":"BFnrneph201533_CR175","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/annrheumdis-2012-202675","volume":"73","author":"HS Lee","year":"2014","unstructured":"Lee, H. S. et al. Ethnic specificity of lupus-associated loci identified in a genome-wide association study in Korean women. Ann. Rheum. Dis. 73, 1240\u20131245 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201533_CR176","doi-asserted-by":"publisher","first-page":"e69547","DOI":"10.1371\/journal.pone.0069547","volume":"8","author":"P Liu","year":"2013","unstructured":"Liu, P. et al. IL-10 gene polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis. PLoS One 8, e69547 (2013).","journal-title":"PLoS One"},{"key":"BFnrneph201533_CR177","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ng.468","volume":"41","author":"V Gateva","year":"2009","unstructured":"Gateva, V. et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 41, 1228\u20131233 (2009).","journal-title":"Nat. Genet."},{"key":"BFnrneph201533_CR178","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/gene.2009.19","volume":"10","author":"R Lu","year":"2009","unstructured":"Lu, R. et al. Genetic associations of LYN with systemic lupus erythematosus. Genes Immun. 10, 397\u2013403 (2009).","journal-title":"Genes Immun."},{"key":"BFnrneph201533_CR179","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1136\/ard.2010.140111","volume":"70","author":"XJ Zhou","year":"2011","unstructured":"Zhou, X. J. et al. Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population. Ann. Rheum. Dis. 70, 1330\u20131337 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201533_CR180","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/rheumatology\/keq313","volume":"50","author":"YJ Sheng","year":"2011","unstructured":"Sheng, Y. J. et al. Follow-up study identifies two novel susceptibility loci PRKCB and 8p11.21 for systemic lupus erythematosus. Rheumatology (Oxford) 50, 682\u2013688 (2011).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrneph201533_CR181","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/ng1673","volume":"37","author":"T Vang","year":"2005","unstructured":"Vang, T. et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat. Genet. 37, 1317\u20131319 (2005).","journal-title":"Nat. Genet."},{"key":"BFnrneph201533_CR182","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.4049\/jimmunol.0713370","volume":"182","author":"AF Arechiga","year":"2009","unstructured":"Arechiga, A. F. et al. Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J. Immunol. 182, 3343\u20133347 (2009).","journal-title":"J. Immunol."},{"key":"BFnrneph201533_CR183","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1172\/JCI45790","volume":"121","author":"L Menard","year":"2011","unstructured":"Menard, L. et al. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J. Clin. Invest. 121, 3635\u201344 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201533_CR184","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/ejhg.2012.277","volume":"21","author":"C Wang","year":"2013","unstructured":"Wang, C. et al. Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations. Eur. J. Hum. Genet. 21, 994\u2013999 (2013).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnrneph201533_CR185","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/art.24387","volume":"60","author":"B Namjou","year":"2009","unstructured":"Namjou, B. et al. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis Rheum. 60, 1085\u20131095 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201533_CR186","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/ng.81","volume":"40","author":"JB Harley","year":"2008","unstructured":"Harley, J. B. et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet. 40, 204\u2013210 (2008).","journal-title":"Nat. Genet."},{"key":"BFnrneph201533_CR187","doi-asserted-by":"publisher","first-page":"e1003554","DOI":"10.1371\/journal.pgen.1003554","volume":"9","author":"H Manku","year":"2013","unstructured":"Manku, H. et al. Trans-ancestral studies fine map the SLE-susceptibility locus TNFSF4. PLoS Genet. 9, e1003554 (2013).","journal-title":"PLoS Genet."},{"key":"BFnrneph201533_CR188","doi-asserted-by":"publisher","first-page":"e1003222","DOI":"10.1371\/journal.pgen.1003222","volume":"9","author":"JE Molineros","year":"2013","unstructured":"Molineros, J. E. et al. Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production. PLoS Genet. 9, e1003222 (2013).","journal-title":"PLoS Genet."},{"key":"BFnrneph201533_CR189","doi-asserted-by":"publisher","first-page":"e1002341","DOI":"10.1371\/journal.pgen.1002341","volume":"7","author":"DS Cunninghame Graham","year":"2011","unstructured":"Cunninghame Graham, D. S. et al. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet. 7, e1002341 (2011).","journal-title":"PLoS Genet."},{"key":"BFnrneph201533_CR190","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/ng.2756","volume":"45","author":"HJ Westra","year":"2013","unstructured":"Westra, H. J. et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 45, 1238\u20131243 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrneph201533_CR191","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/annrheumdis-2012-201851","volume":"72","author":"KM Kaufman","year":"2013","unstructured":"Kaufman, K. M. et al. Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Ann. Rheum. Dis. 72, 437\u2013444 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201533_CR192","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jaut.2012.12.012","volume":"41","author":"KA Koelsch","year":"2013","unstructured":"Koelsch, K. A. et al. Functional characterization of the MECP2\/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse. J. Autoimmun. 41, 168\u2013174 (2013).","journal-title":"J. Autoimmun."},{"key":"BFnrneph201533_CR193","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/ng1782","volume":"38","author":"RR Graham","year":"2006","unstructured":"Graham, R. R. et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat. Genet. 38, 550\u2013555 (2006).","journal-title":"Nat. Genet."},{"key":"BFnrneph201533_CR194","doi-asserted-by":"publisher","first-page":"6758","DOI":"10.1073\/pnas.0701266104","volume":"104","author":"RR Graham","year":"2007","unstructured":"Graham, R. R. et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc. Natl Acad. Sci. USA 104, 6758\u20136763 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201533_CR195","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/hmg\/ddm359","volume":"17","author":"S Sigurdsson","year":"2008","unstructured":"Sigurdsson, S. et al. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum. Mol. Genet. 17, 872\u2013881 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph201533_CR196","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3899\/jrheum.090440","volume":"37","author":"SE Lofgren","year":"2010","unstructured":"Lofgren, S. E. et al. Promoter insertion\/deletion in the IRF5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells. J. Rheumatol. 37, 574\u2013578 (2010).","journal-title":"J. Rheumatol."},{"key":"BFnrneph201533_CR197","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/art.30193","volume":"63","author":"Q Fu","year":"2011","unstructured":"Fu, Q. et al. Association of a functional IRF7 variant with systemic lupus erythematosus. Arthritis Rheum. 63, 749\u2013754 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201533_CR198","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/art.27182","volume":"62","author":"R Salloum","year":"2010","unstructured":"Salloum, R. et al. Genetic variation at the IRF7\/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients. Arthritis Rheum. 62, 553\u2013561 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201533_CR199","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1073\/pnas.1222798110","volume":"110","author":"R Baccala","year":"2013","unstructured":"Baccala, R. et al. Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus. Proc. Natl Acad. Sci. USA 110, 2940\u20132945 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201533_CR200","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ajhg.2012.02.023","volume":"90","author":"CJ Lessard","year":"2012","unstructured":"Lessard, C. J. et al. Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am. J. Hum. Genet. 90, 648\u2013660 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph201533_CR201","doi-asserted-by":"publisher","first-page":"15838","DOI":"10.1073\/pnas.1001337107","volume":"107","author":"N Shen","year":"2010","unstructured":"Shen, N. et al. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc. Natl Acad. Sci. USA 107, 15838\u201315843 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201533_CR202","doi-asserted-by":"publisher","first-page":"e1003336","DOI":"10.1371\/journal.pgen.1003336","volume":"9","author":"Y Deng","year":"2013","unstructured":"Deng, Y. et al. MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus. PLoS Genet. 9, e1003336 (2013).","journal-title":"PLoS Genet."},{"key":"BFnrneph201533_CR203","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.gene.2013.08.051","volume":"533","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. Association study of TLR-9 polymorphisms and systemic lupus erythematosus in northern Chinese Han population. Gene 533, 385\u2013388 (2014).","journal-title":"Gene"},{"key":"BFnrneph201533_CR204","doi-asserted-by":"publisher","first-page":"e1003750","DOI":"10.1371\/journal.pgen.1003750","volume":"9","author":"S Wang","year":"2013","unstructured":"Wang, S. et al. An enhancer element harboring variants associated with systemic lupus erythematosus engages the TNFAIP3 promoter to influence A20 expression. PLoS Genet. 9, e1003750 (2013).","journal-title":"PLoS Genet."},{"key":"BFnrneph201533_CR205","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3899\/jrheum.110590","volume":"39","author":"S Agik","year":"2012","unstructured":"Agik, S. et al. The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes. J. Rheumatol. 39, 73\u20138 (2012).","journal-title":"J. Rheumatol."},{"key":"BFnrneph201533_CR206","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/gene.2012.6","volume":"13","author":"S Wang","year":"2012","unstructured":"Wang, S. et al. A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus. Genes Immun. 13, 380\u2013387 (2012).","journal-title":"Genes Immun."},{"key":"BFnrneph201533_CR207","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1093\/hmg\/ddh275","volume":"13","author":"HD Shin","year":"2004","unstructured":"Shin, H. D. et al. Common DNase I polymorphism associated with autoantibody production among systemic lupus erythematosus patients. Hum. Mol. Genet. 13, 2343\u20132350 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph201533_CR208","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/hmg\/ddp007","volume":"18","author":"S Han","year":"2009","unstructured":"Han, S. et al. Evaluation of imputation-based association in and around the integrin-alpha-M (ITGAM) gene and replication of robust association between a non-synonymous functional variant within ITGAM and systemic lupus erythematosus (SLE). Hum. Mol. Genet. 18, 1171\u20131180 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph201533_CR209","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1136\/annrheumdis-2012-201390","volume":"71","author":"B Rhodes","year":"2012","unstructured":"Rhodes, B. et al. The rs1143679 (R77H) lupus associated variant of ITGAM (CD11b) impairs complement receptor 3 mediated functions in human monocytes. Ann. Rheum. Dis. 71, 2028\u20132034 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201533_CR210","doi-asserted-by":"publisher","first-page":"e57082","DOI":"10.1371\/journal.pone.0057082","volume":"8","author":"L Fossati-Jimack","year":"2013","unstructured":"Fossati-Jimack, L. et al. Phagocytosis is the main CR3-mediated function affected by the lupus-associated variant of CD11b in human myeloid cells. PLoS One 8, e57082 (2013).","journal-title":"PLoS One"},{"key":"BFnrneph201533_CR211","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/gene.2010.73","volume":"12","author":"B Namjou","year":"2011","unstructured":"Namjou, B. et al. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun. 12, 270\u2013279 (2011).","journal-title":"Genes Immun."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.33","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T23:29:06Z","timestamp":1717802946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2015.33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,31]]},"references-count":211,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["BFnrneph201533"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2015.33","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,31]]},"assertion":[{"value":"31 March 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}